Evidence map›Paper›PMID 26829649›Full record

ArticleNature neuroscience2016

Engineering microdeletions and microduplications by targeting segmental duplications with CRISPR.

Derek J C Tai, Ashok Ragavendran, Poornima Manavalan, Alexei Stortchevoi, Catarina M Seabra, Serkan Erdin, Ryan L Collins, Ian Blumenthal, Xiaoli Chen, Yiping Shen and 5 more

Abstract read
In one paragraph

Article in Nature neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. Article
  2. Article
  3. Clinical,medRxiv : the preprint server for health sciences · 2026
    Article
  4. Article
  5. Frontiers in molecular neuroscience · 2026
    Article
  6. Article
  7. CRISPR-engineered deletion ofbioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Cell villages and Dirichlet modeling map human cell fitness genetics.bioRxiv : the preprint server for biology · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Derek J C TaiMolecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA.
Ashok RagavendranMolecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA.
Poornima ManavalanMolecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA.
Alexei StortchevoiMolecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA.
Catarina M SeabraMolecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA.
Serkan ErdinMolecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA.
Ryan L CollinsMolecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA.ORCID http://orcid.org/0000-0003-1268-9995
Ian BlumenthalMolecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA.
Xiaoli ChenBeijing Municipal Key Laboratory of Child Development and Nutriomics, Capital Institute of Pediatrics, Beijing, China.
Yiping ShenDepartment of Laboratory Medicine, Boston Children's Hospital, Boston, Massachusetts, USA.
Mustafa SahinDepartment of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.ORCID http://orcid.org/0000-0001-7044-2953
Chengsheng ZhangThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
Charles LeeThe Jackson Laboratory for Genomic Medicine, Farmington, Connecticut, USA.
James F GusellaMolecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA.
Michael E TalkowskiMolecular Neurogenetics Unit, Center for Human Genetic Research, Massachusetts General Hospital, Boston, Massachusetts, USA.

Funding

Shared Resource ManagementP30CA034196 · NCI · JACKSON LABORATORY · PI William Carl Skarnes · 1985 to 2026
$61.9M
RAPID GENE DISCOVERYP01GM061354 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI TALKOWSKI, MICHAEL E · 2001 to 2019
$24.3M
An Integrative Analysis of Structural Variation for the 1000 Genomes ProjectU41HG007497 · NHGRI · JACKSON LABORATORY · PI LEE, CHARLES · 2013 to 2017
$13.0M
Center for Genomic and Phenomic Studies in AutismU24MH081810 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI LAJONCHERE, CLARA M · 2007 to 2011
$8.3M
Mouse Neurodevelopmental Behavior CoreU54HD090255 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI POMEROY, SCOTT LOREN · 2016 to 2020
$5.2M
Dissecting recurrent microdeletion syndromes using dual-guide genome editingR01NS093200 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI GUSELLA, JAMES F · 2015 to 2019
$2.9M
Complex Genetic Architecture of Chromosomal Aberrations in AutismR00MH095867 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI TALKOWSKI, MICHAEL E · 2014 to 2016
$747k
Complex Genetic Architecture of Chromosomal Aberrations in AutismK99MH095867 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI TALKOWSKI, MICHAEL E · 2012 to 2013
$186k
NCI NIH HHS P30 CA034196NCI NIH HHS P30CA034196NHGRI NIH HHS U41 HG007497NHGRI NIH HHS U41HG007497NICHD NIH HHS U54 HD090255NIGMS NIH HHS P01 GM061354NIGMS NIH HHS P01GM061354NIMH NIH HHS 1U24MH081810NIMH NIH HHS K99 MH095867NIMH NIH HHS R00 MH095867NIMH NIH HHS R00MH095867NIMH NIH HHS U24 MH081810NINDS NIH HHS R01 NS093200NINDS NIH HHS R01NS093200
6 · The paper itself

Abstract

Recurrent, reciprocal genomic disorders resulting from non-allelic homologous recombination (NAHR) between near-identical segmental duplications (SDs) are a major cause of human disease, often producing phenotypically distinct syndromes. The genomic architecture of flanking SDs presents a challenge for modeling these syndromes; however, the capability to efficiently generate reciprocal copy number variants (CNVs) that mimic NAHR would represent a valuable modeling tool. We describe here a CRISPR/Cas9 genome engineering method, single-guide CRISPR/Cas targeting of repetitive elements (SCORE), to model reciprocal genomic disorders and demonstrate its capabilities by generating reciprocal CNVs of 16p11.2 and 15q13.3, including alteration of one copy-equivalent of the SDs that mediate NAHR in vivo. The method is reproducible, and RNA sequencing reliably clusters transcriptional signatures from human subjects with in vivo CNVs and their corresponding in vitro models. This new approach will provide broad applicability for the study of genomic disorders and, with further development, may also permit efficient correction of these defects.

Indexed as

Autistic DisorderChromosome DeletionChromosome DisordersChromosomes, Human, Pair 15Chromosomes, Human, Pair 16Clustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsDNA Copy Number VariationsGenetic EngineeringHumansIntellectual DisabilitySegmental Duplications, GenomicSeizuresSequence Deletion

Identifiers

PMID26829649
PMCPMC4903018

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.